Reopro and Captopril drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Reopro (abciximab) and Captopril (captopril). Common drug interactions include blood pressure systolic decreased among females and thrombocytopenia among males.

The phase IV clinical study analyzes what interactions people have when they take Reopro and Captopril. It is created by eHealthMe based on reports of 34 people who take the same drugs from the FDA, and is updated regularly.

What is Reopro?

Reopro has active ingredients of abciximab. eHealthMe is studying from 4,782 Reopro users. Check the latest studies of Reopro.

What is Captopril?

Captopril has active ingredients of captopril. It is often used in high blood pressure. eHealthMe is studying from 17,438 Captopril users. Check the latest studies of Captopril.



On Jul, 10, 2026

34 people who take Reopro and Captopril together, and have interactions are studied.

Reopro and Captopril drug interactions.

What are the common drug interactions of Reopro and Captopril, by gender? *:

female:

  1. Blood pressure systolic decreased
  2. Blood triglycerides increased
  3. Body temperature increased
  4. Cardiac arrest
  5. Cardiac failure
  6. Cerebral haemorrhage (bleeding within the brain)
  7. Coma (state of unconsciousness lasting more than six hours)
  8. Convulsions (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled of muscles contract and relax rapidly and repeatedly)
  9. Coronary artery occlusion (complete obstruction of blood flow in a coronary artery)
  10. Death

male:

  1. Thrombocytopenia (decrease of platelets in blood)
  2. Sudden cardiac death
  3. Renal failure acute (rapid kidney dysfunction)
  4. Apnoea (suspension of external breathing)
  5. Cerebral infarction (less blood supply to brain resulting tissue damage)
  6. Cerebrovascular accident (sudden death of some brain cells due to lack of oxygen when the blood flow to the brain is impaired by blockage or rupture)
  7. Coma (state of unconsciousness lasting more than six hours)
  8. Haematemesis (vomiting of blood)
  9. Haematocrit decreased
  10. Muscle spasms (muscle contraction)

What are the common drug interactions of Reopro and Captopril, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

  1. Aortic thrombosis (formation of a blood clot inside aorta)
  2. Gastrointestinal haemorrhage (bleeding gastrointestinal tract)
  3. Pulmonary oedema (fluid accumulation in the lungs)
  4. Shock haemorrhagic (a life-threatening condition with symptoms like low blood pressure, weakness, shallow breathing, cold, clammy skin due to excess bleeding)
  5. Thromboembolism (obstruction of artery by blood clot)
  6. Vaginal haemorrhage (vaginal bleeding)

50-59:

  1. Blood glucose increased
  2. Blood lactic acid decreased
  3. Blood pressure decreased
  4. Blood pressure systolic decreased
  5. Blood triglycerides increased
  6. Body temperature increased
  7. Cardiac failure
  8. Catheter site haemorrhage (bleeding at catheter site)
  9. Cerebral haemorrhage (bleeding within the brain)
  10. Chest pain

60+:

  1. Thrombocytopenia (decrease of platelets in blood)
  2. Cardiogenic shock (inadequate circulation of blood)
  3. Haematemesis (vomiting of blood)
  4. Haematoma (collection of blood outside the blood vessels)
  5. Muscle spasms (muscle contraction)
  6. Paralysis flaccid (abnormal condition characterized by the weakening or the loss of muscle tone)
  7. Platelet count decreased
  8. Pupil fixed
  9. Reocclusion (obstruction or closing of a blood vessel that may occur after once treated)
  10. Ventricular tachycardia (rapid heartbeat that originates in one of the lower chambers (the ventricles) of the heart)

What are the existing conditions these people have? *

  1. Acute Myocardial Infarction (acute heart attack): 5 people, 14.71%

* Approximation only. Some reports may have incomplete information.

Do you take Reopro and Captopril?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Reopro and Captopril:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Reopro:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Captopril:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Reopro and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Captopril and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on abciximab and captopril (the active ingredients of Reopro and Captopril, respectively), and Reopro and Captopril (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: